Since its emergence as a global epidemic 30 years ago, HIV/AIDS has been transformed from a fatal illness into a manageable chronic disease owing to the powerful antiretroviral therapies discovered and developed by chemists, virologists, clinicians, and many others working together at academic, government, and biopharmaceutical industry laboratories around the world. This conversation will focus on the fascinating story of chemical innovation underlying the development of effective treatments along with their global impact. The event, moderated by Jeffrey Sturchio, will engage four luminaries in HIV/AIDS research, policy, and practice—Gregg Alton and Norbert Bischofberger from Gilead Sciences, and Sir Richard Feachem and Paul Volberding from the University of California, San Francisco—in a conversation about both the remarkable progress we have seen in HIV therapies and the challenges still to be met.
Date and Time
Tuesday Dec 4, 2012
5:00 PM - 8:30 PM PST
Website
